Comac Medical is excited to announce our participation in this year’s ESMO 2024 Congress in Barcelona, Spain, from 13-17 September! As one of the premier events in the oncology field, ESMO 2024 presents a valuable opportunity to connect with professionals and companies at the forefront of cancer research, drug development, and clinical trials.

Join us to discuss key advancements and strategies in oncology clinical trials, including patient recruitment, site management, regulatory affairs, and data management. Learn more about how Comac Medical can support your oncology development needs across all phases of clinical research. Representing our team at this prestigious event will be Christ Serra, VP of Business Development, and Martina Forte, BD & Marketing Manager. Both Christ and Martina are ready to meet with you to explore potential partnerships and innovative solutions for your clinical programs.

With over 25 years of experience in conducting and managing oncology clinical trials—spanning early-phase clinical trials (Phase I), late-phase trials (Phase II-III), and post-marketing studies (Phase IV)—Comac Medical has a proven track record of delivering high-quality, cost-effective results that accelerate drug development and bring innovative cancer therapies to market. From patient recruitment and site selection to regulatory support and clinical trial monitoring, we are dedicated to advancing oncology research in collaboration with our global partners.

Don’t miss the opportunity to engage with our clinical trial experts!

Check out our Oncology experience, click here.